A Randomized, Double-Blind, Single Dose, Four-Period, Six-Treatment, Placebo-Controlled, Balanced, Incomplete Block, Cross-Over, Study of Four Doses of Inhaled PT001 in Patients With Mild to Moderate COPD, Compared to Open Label Tiotropium.

Trial Profile

A Randomized, Double-Blind, Single Dose, Four-Period, Six-Treatment, Placebo-Controlled, Balanced, Incomplete Block, Cross-Over, Study of Four Doses of Inhaled PT001 in Patients With Mild to Moderate COPD, Compared to Open Label Tiotropium.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 20 Jun 2013

At a glance

  • Drugs Glycopyrrolate (Primary) ; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Pearl Therapeutics
  • Most Recent Events

    • 19 May 2010 Results presented at the annual meeting of the American Thoracic Society.
    • 18 May 2010 Results have been presented at the 106th International Conference of the American Thoracic Society.
    • 18 May 2010 Results reported at ATS according to Pearl Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top